Advances In Cancer Vaccines

Day 1 |   Day 2 |   Advances in Cancer Vaccines Brochure

The Advances in Cancer Vaccines meeting is focused specifically on biological therapies that partner with the immune system to fight cancer.  Key players in industry, academia, and government will address the progress being made in such challenging areas as humanized monoclonal antibodies, soluble receptors, immunorepressants and tumor treatment.

Join colleagues from around the world to discuss the current challenges and breakthrough successes in the pursuit of an immunotherapeutic approach to attacking cancer, this stealer of lives.

Opportunities and Challenges for Cancer Vaccines
Tibor Keler, Ph.D., Senior Vice President and Chief Scientific Officer, Celldex Therapeutics Inc.

Vaccine, Immunotherapy and the Immunological Constant or Rejection
Francesco M. Marincola, Ph.D., Chief, Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health

Dendritic Cell Tumor Fusions from the Bench to the Bedside
David Avigan, M.D., Director, Hematological Malignancies/Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School

 GVAX Immunotherapy for Prostate Cancer
Kristen M. Hege, M.D., Vice President, Clinical Research and Development, Cell Genesys

Day 1 |  Day 2